Skip to main content
. 2022 Jan 19;128(8):1692–1698. doi: 10.1002/cncr.34088

Figure 1.

Figure 1

Consolidated Standards of Reporting Trials diagram showing the patient disposition. AE indicates adverse event; FosAPR, fosaprepitant; FosNTP, fosnetupitant; SAE, serious adverse event.